SCHEMBL21881892

SCHEMBL21881892

CP(C)(=O)c1ccc(-c2cc(-c3ccccc3)ccc2-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc5ccccc5c4)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTGS2 P35354 1/20 0.37
SIRT2 Q8IXJ6 3/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
GSTP1 P09211 1/20 0.36
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881772 0.88 MEN1 (0.41) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL31642878 0.87 L3MBTL1 (0.38) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21250857 0.85 ESR1 (0.39) MEN1KMT2ASMN1; SMN2PTGS2ESR1
SCHEMBL24377032 0.84 ESR1 (0.46) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL24377047 0.84 ESR1 (0.46) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL26591969 0.84 MEN1 (0.49) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL23633690 0.84 ESR1 (0.47) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL24377048 0.84 MEN1 (0.47) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL21881919 0.83 GSTP1 (0.38) SMN1; SMN2ALDH1A1CYP1A2HSD17B10GSTP1
SCHEMBL26592247 0.83 MEN1 (0.45) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885SMN1; SMN2 2233/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885SMN1; SMN2 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.